Anne Wojcicki will buy 23 Andme and her data for $ 305 million
The founder of 23Andme, Anne Wojcicki, speaks during a supervision committee of the Government Supervision and Reform Chamber in Washington,…
The founder of 23Andme, Anne Wojcicki, speaks during a supervision committee of the Government Supervision and Reform Chamber in Washington,…
The low performance of biopharmaceutical actions versus the widest market for a third consecutive year is an opportunity for investors,…
A view of the 23ndme headquarters in Sunnyvale, California, on March 25, 2025. Tayfun Coskun | Anadolu | Getty images…
The Lilly Biotechnology Center in San Diego, California, on March 1, 2023. Mike Blake | Reuters The actions of drug…
JPMorgan is eyeing some drugmakers ahead of their earnings reports as investors continue to sell shares of major technology companies.…